Annosquacin B induces mitochondrial apoptosis in multidrug resistant human breast cancer cell line MCF-7/ADR through selectively modulating MAPKs pathways

References

• Alali FQ, Rogers L, Zhang Y, Mclaughlin JL. 1999. Goniotriocin and (2,4-cis- and -trans)-xylomaticinones, bioactive annonaceous acetogenins from Goniothalamus giganteus. J Nat Prod. 62:31–34.
   PubMed Web of Science ®Google Scholar
• Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar SV, Limtrakul PN. 2002. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol. 64:573–582.
   PubMed Web of Science ®Google Scholar
• Barancik M, Bohacova V, Kvackajova J, Hudecova S, Krizanova O, Breier A. 2001. SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance. Eur J Pharm Sci. 14:29–36.
   PubMed Web of Science ®Google Scholar
• Bermejo A, Figadere B, Zafra-Polo MC, Barrachina I, Estornell E, Cortes D. 2005. Acetogenins from Annonaceae: recent progress in isolation, synthesis and mechanisms of action. Nat Prod Rep. 22:269–303.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen JW, Li X. 2012a. Monotetrahydrofuran annonaceous acetogenins from the seeds of Annona squamosa. Phytochem Lett. 5:33–36.
   Web of Science ®Google Scholar
• Chen Y, Chen JW, Wang Y, Xu SS, Li X. 2012b. Six cytotoxic annonaceous acetogenins from Annona squamosa seeds. Food Chem. 135:960–966.
   PubMed Web of Science ®Google Scholar
• Chen Y, Xu SS, Chen JW, Wang Y, Xu HQ, Fan NB, Li X. 2012c. Anti-tumor activity of Annona squamosa seeds extract containing annonaceous acetogenin compounds. J Ethnopharmacol. 142:462–466.
   PubMed Web of Science ®Google Scholar
• Choi JH, Lim HY, Joo HJ, Kim HS, Yi JW, Kim HC, Cho YK, Kim MW, Lee KB. 2002. Expression of multidrug resistance-associated protein1, P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection. Br. J. Cancer. 86:1578–1585.
   PubMed Web of Science ®Google Scholar
• Ding S, Chamberlain M, McLaren A, Goh L-b, Duncan I, Wolf CR. 2001. Cross-talk between signalling pathways and the multidrug resistant protein MDR-1. Br J Cancer. 85:1175–1184.
   PubMed Web of Science ®Google Scholar
• Emanuel SL, Chamberlin HA, Cohen D. 1999. Antimitotic drugs cause increased tumorigenicity of multidrug resistant cells. Int J Oncol. 14:487–494.
   PubMed Web of Science ®Google Scholar
• Fu LW, Tan BY, Liang YJ, Pan QC, Huang HB, Feng GK. 1999. The circumvention of tumor multidrug resistance by bullatacin and its mechanism. Acta Pharm Sin. 34:268–271.
   Google Scholar
• Green DR, Kroemer G. 2005. Pharmacological manipulation of cell death: clinical applications in sight. J Clin Invest. 115:2610–2617.
   PubMed Web of Science ®Google Scholar
• He H, Zang L, Feng YS, Chen LX, Kang N, Tashiro S, Onodera S, Qiu F, Ikejima T. 2013. Physalin A induces apoptosis via p53-Noxa-mediated ROS generation, and autophagy plays a protective role through p38-NF-KB survival pathway in A375-S2 cells. J. Ethnopharmacol. 148:544–555.
   PubMed Web of Science ®Google Scholar
• Hui YH, Rupprecht JK, Liu YM, Anderson JE, Smith DL, Chang CJ, Mclaughlin JL. 1989. Bullatacin and bullatacinone: two highly potent bioactive acetogenins from Annona bullata. J Nat Prod. 52:463–477.
   PubMed Web of Science ®Google Scholar
• Hwang CH, Keum G, Sohn K, Lee DH, Lee E. 2005. Stereoselective synthesis of (-)-jimenezin. Tetrahedron Lett. 46:6621–6623.
   Web of Science ®Google Scholar
• Kowalski P, Stein U, Scheffer GL, Lage H. 2002. Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2. Cancer Gene Ther. 9:579–586.
   PubMed Web of Science ®Google Scholar
• Lee YJ, Galoforo SS, Berns CM, Chen JC, Davis BH, Sim JE, Corry PM, Spitz DR. 1998. Glucose deprivation-induced cytotoxicity and alterations in mitogen-activated protein kinase activation are mediated by oxidative stress in multidrug-resistant human breast carcinoma cells. J Biol Chem. 273:5294–5299.
   PubMed Web of Science ®Google Scholar
• Liu XD, Sun H, Liu GT. 2010. 5-Bromotetrandrine enhances the sensitivity of doxorubicin-induced apoptosis in intrinsic resistant human hepatic cancer Bel7402 cells. Cancer Lett. 292:24–31.
   PubMed Web of Science ®Google Scholar
• Ludwig A, Dietel M, Lage H. 2002. Identification of differentially expressed genes in classical and atypical multidrug-resistant gastric carcinoma cells. Anticancer Res. 22:3213–3221.
   PubMed Web of Science ®Google Scholar
• Makabe H, Higuchi M, Konno H, Murai M, Miyoshi H. 2005. Synthesis of (4R, 15R, 16R, 21S)- and (4R, 15S, 16S, 21S)-rollicosin. Tetrahedron Lett. 46:4671–4675.
   Web of Science ®Google Scholar
• Oberlies NH, Croy VL, Harrison ML, Mclaughlin JL. 1997. The annonaceous acetogenin bullatacin is cytotoxic against multidrug-resistant human mammary adenocarcinoma cells. Cancer Lett. 115:73–79.
   PubMed Web of Science ®Google Scholar
• Raynaud S, Nemati F, Miccoli L, Michel P, Poupon M, Fourneau C, Laurens A, Hocquemiller R. 1999. Antitumoral effects of squamocin on parental and multidrug resistant MCF7 (human breast adenocarcinoma) cell lines. Life Sci. 65:525–533.
   PubMed Web of Science ®Google Scholar
• Takahashi S, Kubota A, Nakata T. 2002. Total synthesis of muconin. Tetrahedron Lett. 43:8661–8664.
   Web of Science ®Google Scholar
• Tang XQ, Bi H, Feng JQ, Hu B, Feng JQ, Cao JG. 2005. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR. Acta Pharmacol Sin. 26:1009–1016.
   PubMed Web of Science ®Google Scholar
• Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1326–1331.
   PubMed Web of Science ®Google Scholar
• Yang HJ, Li X, Zhang N, Chen JW, Wang MY. 2009. Two new cytotoxic acetogenins from Annona squamosa. J Asian Nat Prod Res. 11:250–256.
   PubMed Web of Science ®Google Scholar
• Yazbak A, Sinha SC, Keinan E. 1998. Total synthesis of Uvaricin. J Org Chem. 63:5863–5868.
   PubMed Web of Science ®Google Scholar
• Zhu LT, Zhao L, Wang H, Wang Y, Pan D, Yao J, Li ZY, Wu GZ, Guo QL. 2013. Oroxylin A reverses P-glycoprotein-mediated multidrug resistance of MCF7/ADR cells by G2/M arrest. Toxicol Lett 219:107–115.
   PubMed Web of Science ®Google Scholar